IL5 and Alzheimer disease: Additionally, the incorporation of neuroinflammatory markers IL-5, -6, -10 and markers measuring vascular health like PCAM and VCAM will be analyzed in the future to help explore whether alternative pathways may be responsible for the increased incidence of AD in Mexican Americans, potentially linked to metabolic or vascular risk factors.